Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Separation Science|April 30, 2021
Photoresponsive molecularly imprinted polymers based on 4-[(4-methacryloyloxy)phenylazo] benzenesulfonic acid for the determination of sulfamethazineWeihong Huang, Haojie Si, Liming Zhang, et al.
The Annals of Thoracic Surgery|June 18, 2025
Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung CancerJialiang Wen, Yichen Dong, Tao Chen, et al.
International Journal of Surgery (London, England)|September 27, 2023
The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for nonsmall cell lung cancer: a retrospective cohort studyLong Xu, Haojie Si, Hang Su, et al.
The Annals of Thoracic Surgery|March 18, 2024
Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung AdenocarcinomaHaojie Si, Long Xu, Yue Zhao, et al.
British Journal of Cancer|April 4, 2023
Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysisLong Xu, Hang Su, Shengnan Zhao, et al.
JTO Clinical and Research Reports|January 6, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief ReportYichen Dong, Long Xu, Jialiang Wen, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 19, 2025
Validation and refinement of the ninth edition ypN descriptor in patients with non-small cell lung cancer receiving neoadjuvant therapyHaojie Si, Yuntao Feng, Yichen Dong, et al.
Med (New York, N.Y.)|February 26, 2026
A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacyYichen Dong, Xuanhao Xu, Haojie Si, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2023
Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomasJunqiang Fan, Jie Yao, Haojie Si, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 19, 2024
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancerLong Xu, Haojie Si, Fenghui Zhuang, et al.
Pageof 1